Bridging the Gap: Why Medicaid Coverage for Incarcerated Individuals Is a Critical Step Toward Recovery
In recent years, a growing number of states have recognized a troubling pattern: individuals leaving prison are at significantly higher risk of opioid overdose,...
Federal Agencies Plan $20 Million Investment to Boost Behavioral Health Technology
In an ambitious move aimed at transforming the behavioral health sector, two pivotal federal agencies—the Substance Abuse and Mental Health Services Administration (SAMHSA) and...
Strengthening Privacy for Substance Use Disorder Patients: What the New HHS Confidentiality Rule Means
Protecting patient privacy is a foundational principle of healthcare — especially for individuals seeking treatment for substance use disorder (SUD). Recognizing the unique challenges...
The future of substance use disorder treatment: Navigating change while upholding core values
The future of substance use disorder treatment is evolving rapidly, driven by advances in technology, regulatory shifts, and new medications. Providers looking to thrive...
Redefining Behavioral Health Quality: Embracing Measurement-Informed Care for a More Accountable Future
For decades, the behavioral health industry has lacked a unified and scalable system for defining, measuring, and improving clinical outcomes. The absence of standardized...
Breaking Down the SAMHSA Opioid Treatment Rule 2024: What It Means for Patients and Providers
In a pivotal move aimed at modernizing addiction care and expanding access to opioid use disorder (OUD) treatment, the Substance Abuse and Mental Health...
